Name | Eslicarbazepine |
---|---|
Synonyms |
(+)-Licarbazepine
(S)-(+)-10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepine-5-carboxamide (S)-(+)-licarbazepine 5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-, (10S)- T C676 BN&T&J BVZ IQ &&S Form MHD (S)-10-hydroxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide Eslicarbazepine 5-hydroxy-4a,5-dihydro-4H-dibenzo[b,f]azepine-10-carboxamide (10S)-10-Hydroxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide S-licarbazepine (S)-Licarbazepine S5VXA428R4 |
Description | Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures. |
---|---|
Related Catalog | |
In Vivo | Eslicarbazepine is an anti-epileptic drug, chemically related to carbamazepine but with a more favorable safety profile. Eslicarbazepine acetate is a prodrug for eslicarbazepine (S-licarbazepine), which is a dual a dual Inhibitor of β-Secretase and voltage-gated sodium channel[1][2]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 431.3±55.0 °C at 760 mmHg |
Melting Point | 188-190°C |
Molecular Formula | C15H14N2O2 |
Molecular Weight | 254.284 |
Flash Point | 214.6±31.5 °C |
Exact Mass | 254.105530 |
PSA | 66.56000 |
LogP | 0.93 |
Vapour Pressure | 0.0±1.1 mmHg at 25°C |
Index of Refraction | 1.677 |
Storage condition | 2-8℃ |
HS Code | 2933990090 |
---|
Precursor 6 | |
---|---|
DownStream 0 |
HS Code | 2933990090 |
---|---|
Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |